Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a... see more

Bullboard (TSX:SVA)

View:
Comment by woundedkneeon Nov 24, 2024 9:22am

RE:Looks to me

Diluted,,,jeez
Post by woundedkneeon Nov 24, 2024 9:21am

Looks to me

Like this is becoming so heavily deluted that maybe the sometimes lofty share price predictions have factored in a post consolidation price. Dr. Witkowski's reports don't seem to have the ...more  
Post by Jonathon Brownon Nov 21, 2024 6:55am

Buzz on the Bullboards: Bombardier, world woes, a smart fridge, and top shelf weed

Post by edroseon Nov 15, 2024 7:01am

loooking at this company it's been taking them years

to enroll patients and it takes years to get data to get fda or hpb in canada to see if they would approve this treatment which would help thousands of type 1 diabetics 
Comment by palladium17on Nov 09, 2024 2:33pm

RE:RE:RE:this board

RixPix you are right it is very little.
Comment by rixpixon Nov 01, 2024 7:45am

RE:RE:this board

Half a million shares shorted is nothing for SVA.  A Private Placement was done 2 months ago so having some shares shorted is nothing important.  GL.
Comment by rixpixon Nov 01, 2024 7:40am

RE:this board

Hey WK. They've moved on, but not because they sold. They're all on another site. CEO . Ca.  Bioteck signed up as RixPix before I went there and I'm there too now. 
Comment by bbowleson Oct 29, 2024 12:03pm

RE:this board

Yep everyone has left this submarine except for the shorts.   Number of Shares Shorted Net Change Oct 15, 2024 593,320 175,757
Post by woundedkneeon Oct 29, 2024 9:09am

this board

This board is no fun. Where did all the posters go from a couple of years ago? You know, the ones critisizing "spillup". Obviously they have sold and moved on. This is my second go around ...more  
Comment by rixpixon Oct 05, 2024 8:28am

RE:RE:RE:Bought a few

I'm still in Europe so it's hard to follow anything that's EST based, but no, I didn't notice because I never follow any stock hourly. Good job in buying more. I think it was a wise ...more  
Comment by woundedkneeon Oct 03, 2024 11:38am

RE:RE:Bought a few

Hi rixpix...just bought 120k today  rounding out at 150. Hope you noticed the little uptik
Comment by rixpixon Sep 29, 2024 4:02pm

RE:Bought a few

Hey WK.  Welcome back as a shareholder.  While you bought a few, I bought more through the latest PP.  I think you'll do fine, but I've been wrong before. GL
Post by woundedkneeon Sep 23, 2024 3:50pm

Bought a few

Naturally, most traded on the grays. Only in for 30k at .25 and .255 Not many of the old posters left.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities